Immuno-Deficiency: Clinical Trials

1 trial for Immuno-Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Immuno-Deficiency: new trials by email Literature Review of Immuno-Deficiency trials Research Report on Immuno-Deficiency

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19
SARS-CoV-2 convalescent plasma - Covid19, Immuno-Deficiency
Phase 3UnknownUniversity Hospital, Geneva1002021-04-082021-04-08

Narrower conditions

COVID-19 (1)  ·  Frailty (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Interventions

COVID-19 Serotherapy (1)

Sponsors

University Hospital, Geneva (1)

Countries

Switzerland (1)

Top investigators

Enos Bernasconi, MD (1)  ·  Laurent Kaiser, MD (1)  ·  Maja Weisser, MD (1)